PMID: 7711418Dec 1, 1994Paper

Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. I. Uric acid kinetics

The Clinical Investigator
W LöfflerN Zöllner


The interaction of allopurinol (300 mg/day) and hydrochlorothiazide (50 mg/day) was studied in seven healthy male volunteers during prolonged coadministration of the two drugs using defined dietary conditions. A formula diet was administered with the allopurinol throughout the 24-day study, while hydrochlorothiazide was added during days 11-21. After the addition of hydrochlorothiazide both plasma uric acid and plasma oxipurinol rose for 6 days--24% and 30%, respectively, compared to steady-state levels during allopurinol alone (P < 0.01 each). In neither substance were variations in renal excretion significant. By the end of combined treatment (day 21), the changes induced by hydrochlorothiazide had already been reversed to a considerable extent. It is concluded that both in normal individuals and in patients with normal renal clearance of uric acid the effect of hydrochlorothiazide on the plasma concentration and renal excretion of oxipurinol is small. When taking both drugs, there is no increased risk during long-term treatment, and a risk is even questionable during the first days.


Nov 1, 1979·European Journal of Clinical Pharmacology·C PonticelliP Gouère
May 1, 1978·Clinical Pharmacology and Therapeutics·K HandeB Chabner
Jun 1, 1976·The American Journal of Medicine·O G Reese, T H Steele
Jan 1, 1990·European Journal of Clinical Pharmacology·G M PetersonG R Taylor
Jun 13, 1987·British Medical Journal·J S Cameron, H A Simmonds
Jan 1, 1987·Journal of Substance Abuse Treatment·D A Calsyn, A J Saxon
Oct 1, 1986·The American Journal of the Medical Sciences·K R Hande
Oct 31, 1986·Clinica Chimica Acta; International Journal of Clinical Chemistry·H A SimmondsP M Davies
Jan 1, 1986·Arthritis and Rheumatism·J Z Singer, S L Wallace
Oct 1, 1969·The American Journal of Medicine·T H Steele, S Oppenheimer
Dec 1, 1970·Metabolism: Clinical and Experimental·W N KelleyJ E Seegmiller
Jan 1, 1974·Clinical and Experimental Pharmacology & Physiology·M H WoodD J Tiller
Jan 15, 1970·The New England Journal of Medicine·J A NicoteroA P Shapiro
Jul 1, 1968·The American Journal of Medicine·G B ElionG H Hitchings
Jul 1, 1966·Biochemical Pharmacology·G B ElionG H Hitchings
Dec 17, 1984·Klinische Wochenschrift·D P Mertz, R Eichhorn
Jun 1, 1981·Archives of Internal Medicine·T YüC Kaung
Jun 1, 1981·Annals of the Rheumatic Diseases·G T McInnesH Jick
Oct 1, 1981·The American Journal of Medicine·G MaschioL Minetti

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.